Long-term results of a RCT | Self-expanding transcatheter vs. surgical aortic valve replacement in intermediate-risk patients.
31 Aug, 2022 | 11:38h | UTCSelf-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial – JAMA Cardiology (link to abstract – $ for full-text)
Original article: Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients – New England Journal of Medicine
Commentary on Twitter
Among intermediate-risk patients with symptomatic severe aortic stenosis, clinical outcomes at 5 years were similar and bioprosthetic valve performance remained stable after transcatheter aortic valve replacement and surgery. https://t.co/rVcVoSMpG4 #OrigResearch
— JAMA Cardiology (@JAMACardio) August 26, 2022